merck sharp dome (Merck & Co)
86
Structured Review
Merck & Co
merck sharp dome
Merck Sharp Dome, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/merck+sharp+dome/dome+merck+sharp/pmc13068602-213-8-8
Average 86 stars, based on 1 article reviews
Merck Sharp Dome, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/merck+sharp+dome/dome+merck+sharp/pmc13068602-213-8-8
Average 86 stars, based on 1 article reviews
merck sharp dome - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
other:Article Title: Role of Local Treatment to the Prostate in Patients With de Novo Low-volume Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors Article Snippet: Honoraria from Janssen, Ipsen, Bristol Myers Squibb, and Article Title: How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab? Article Snippet: Kersti Oselin: Advisory board: Article Title: How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab? Article Snippet: Honoraria: AstraZeneca, Takeda, Article Title: How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab? Article Snippet: Bjørn Henning Grønberg: Advisory board: Janssen, Accord, Article Title: How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab? Article Snippet: Vilde Drageset Haakensen: Advisory board: AstraZeneca, Article Title: How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab? Article Snippet: Research funding: Roche, Article Title: Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale. Article Snippet: Article Title: How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab? Article Snippet: Bjørn Henning Grønberg: Advisory board: Janssen, Accord, |